from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1945/-

LFCtreatmentdescriptionclass of inhibitor

-0.597

Amikacinug/mL Amikacintranslation

-1.474

Cap5-10ug/mL Capreomycintranslation

-1.494

Rox10-50 ug/mL Roxithromycintranslation

-0.429

SM2-5 ug/mL Streptomycintranslation

-2.554

Tet5-10 ug/mL Tetracyclinetranslation

-1.934

Rif0.2-5ug/mL Rifampicintranscription

-0.800

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.862

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.026

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.012

CPZ10-50 ug/mL Chlorpromazinerespiration

0.910

Clofazimine10-13 ug/mL Clofaziminerespiration

0.849

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.343

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.785

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.001

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.697

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.061

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.164

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.389

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.915

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.127

KCN5-20 ug/mL Potassium cyaniderespiration

0.333

NaN30.2-2 mM Sodium aziderespiration

0.143

Nigericin50 uM Nigericinrespiration

0.171

TRC10-150 ug/mL Triclosanrespiration

1.124

TRZ10-25 ug/mL Thioridazinerespiration

-0.766

Valinomycin0.5-10 uM Valinomycinrespiration

0.467

ZnSO42 mM ZnSO4respiration

1.627

menadione6-10 ug/mL Menadionerespiration

0.269

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.346

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.461

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.202

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.359

NRP_1Non-replicating persistence stage 1dosRassociated

0.038

Amp0.2mg/mL AmpicillincellWall

-0.402

Cephalexin20-100 ug/mL CephalexincellWall

-0.307

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.361

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.496

EMB10-20 ug/mL EthambutolcellWall

-0.061

Eta12-40 ug/mL EthionamidecellWall

-0.184

INH0.2-0.4 ug/mL IsoniazidcellWall

0.056

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.403

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.110

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.029

BZA0.12 mg/mL BenzamidearomaticAmides

-0.137

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.369

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.643

H2O24 mM hydrogen peroxideDNAdamaging

2.942

Levo10 ug/mL LevofloxacinDNAdamaging

-0.168

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.579

Novobiocin10 ug/mL NovobiocinDNAdamaging

3.302

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.363

UVUV-irradiationDNAdamaging

-0.332

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.440

Antimycin12.5-50 ug/mL Antimycin A?

-0.211

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.151

PA_110-50 ug/mL Antitubercular compound PA-1?

0.197

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.986

PA8240.2-2 ug/mL PA-824?

-0.848

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.761

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.296

Verapamil50 uM Verapamil?

0.022

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.014

methoxatin10-20 ug/mL Methoxatin?